Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|May 4, 2021
Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemiaShady Adnan-Awad, Matti Kankainen, Satu Mustjoki
Oncotarget|September 27, 2017
Crosstalk between tongue carcinoma cells, extracellular vesicles, and immune cells in in vitro and in vivo modelsAhmed Al-Samadi, Shady Adnan Awad, Katja Tuomainen, et al.
Clinical Laboratory|June 20, 2017
FLT3-ITD Mutations in Egyptian Patients of Acute Myeloid Leukemia: Correlation with Cytogenetic, FAB Subgroups and PrognosisShady Adnan-Awad, Ola Gaber, Soad A Eltokhy, et al.
Clinical Immunology (Orlando, Fla.)|December 10, 2016
A novel class of somatic mutations in blood detected preferentially in CD8+ cellsMiko Valori, Lilja Jansson, Anna Kiviharju, et al.
Clinical Laboratory|April 11, 2019
Prognostic Impact of WT-1 and Survivin Gene Expression in Acute Myeloid Leukemia PatientsShady Adnan-Awad, Yomna M El Meligui, Salem Eid Salem, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 14, 2016
Immunophenotypic Characterization of Cytogenetic Subgroups in Egyptian Pediatric Patients With B-Cell Acute Lymphoblastic LeukemiaShady Adnan Awad, Mahmoud M Kamel, Mahmoud A Ayoub, et al.
Hemasphere|March 2, 2022
Targeting Apoptosis Pathways With BCL2 and MDM2 Inhibitors in Adult B-cell Acute Lymphoblastic LeukemiaHelena Hohtari, Matti Kankainen, Shady Adnan-Awad, et al.
Blood Advances|February 12, 2020
Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemiaShady Adnan Awad, Matti Kankainen, Teija Ojala, et al.
Cell Reports. Medicine|April 23, 2024
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemiaShady Adnan Awad, Olli Dufva, Jay Klievink, et al.
Pageof 3